IFITM2 抗体 (AA 1-132)
Quick Overview for IFITM2 抗体 (AA 1-132) (ABIN7673394)
抗原
See all IFITM2 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
抗原表位
- AA 1-132
-
原理
- IFITM2-specific antibody
-
纯化方法
- Protein A+G purification
-
纯度
- ≥95 % as determined by SDS-PAGE
-
免疫原
-
Immunogen sequence: 1-132aa
Immunogen: interferon induced transmembrane protein 2
-
亚型
- IgG1
-
-
-
-
应用备注
- WB: 1:500 - 1:2000
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
缓冲液
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
注意事项
- Avoid repeated freeze / thaw cycles.
-
储存条件
- -20 °C
-
储存方法
- -20°C for 12 months (Avoid repeated freeze / thaw cycles.)
-
有效期
- 12 months
-
-
- IFITM2 (Interferon Induced Transmembrane Protein 2 (IFITM2))
-
别名
- IFITM2
-
背景
-
Synonyms: Interferon-induced transmembrane protein 2|Dispanin subfamily A member 2c (DSPA2c)|Interferon-inducible protein 1-8D|IFITM2
Background: IFN-induced antiviral protein which inhibits the entry of viruses to the host cell cytoplasm, permitting endocytosis, but preventing subsequent viral fusion and release of viral contents into the cytosol. Active against multiple viruses, including influenza A virus, SARS coronavirus(SARS-CoV), Marburg virus(MARV), Ebola virus(EBOV), Dengue virus(DNV), West Nile virus(WNV), human immunodeficiency virus type 1(HIV-1) and vesicular stomatitis virus(VSV). Can inhibit: influenza virus hemagglutinin protein-mediated viral entry, MARV and EBOV GP1,2-mediated viral entry, SARS-CoV S protein-mediated viral entry and VSV G protein-mediated viral entry. Induces cell cycle arrest and mediates apoptosis by caspase activation and in p53-independent manner.
-
分子量
- 15 kDa
-
基因ID
- 10581
-
UniProt
- Q01629
抗原
-